🇺🇸 FDA
Patent

US 9550742

11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists

granted A61PA61P25/14A61P25/18

Quick answer

US patent 9550742 (11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P25/14, A61P25/18, A61P25/24